Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rajesh Malik Insider Profile
4 Followers
Rajesh Malik, CMO at G1 Therapeutics, holds 159.31K shares in G1 Therapeutics (Ticker: GTHX), holds 0.00 shares in POINT Biopharma Global (Ticker: PNT). Most recently, Rajesh Malik Sold ― shares of G1 Therapeutics on Jul 08, 2024 for an estimated value of 6.19K.
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+34.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
CMO
Roles that Rajesh Malik holds in companies
Most Profitable Insider Trade
Stock:
POINT Biopharma Global
(PNT)
(PNT)
Rating:Informative Buy
Date:Nov 28, 2022 - Nov 28, 2023
Return:+109.50%
The most profitable trade made by Rajesh Malik
Rajesh Malik's Trading History
G1 Therapeutics
Jul 08, 2024
CMO
Informative Sell
6.19K
$578.30K
POINT Biopharma Global
Dec 27, 2023
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Rajesh Malik's performance on stock
You May Also Like
Rajesh Malik insider profile FAQ
What is the percentage of profitable transactions made by Rajesh Malik?
The percentage of profitable transactions made by Rajesh Malik is 71%.
What is the average return per transaction made by Rajesh Malik?
The average return per transaction made by Rajesh Malik is 34.00%.
What stocks does Rajesh Malik hold?
Rajesh Malik holds: GTHX, PNT stocks.
What was Rajesh Malik’s latest transaction?
Rajesh Malik latest transaction was an Informative Sell of $6.19K.
What was Rajesh Malik's most profitable transaction?
Rajesh Malik’s most profitable transaction was an Informative Buy of PNT stock on November 28, 2022. The return on the trade was 109.50%.
What is Rajesh Malik's role in G1 Therapeutics?
Rajesh Malik's role in G1 Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.